Michele I. Korfin
Presently, Michele I. Korfin occupies the position of Chief Operating & Commercial Officer at Gamida Cell Ltd. and Secretary & Trustee at BioNJ, Inc. She is also on the board of Organogenesis Holdings, Inc.
In her past career Ms. Korfin occupied the position of Chief Operating Officer at Tyme Technologies, Inc., Head-Oncology Sales Force at Celgene Corp. and Vice President-Market Access at Kite Pharma, Inc.
She received an MBA from Harvard Business School and an undergraduate degree from Rutgers State University of New Jersey.
Transactions
Date
Transaction
Value
| 02/08/2023 | 92,990 | Award at $0 per share. | 0 |
| 01/28/2022 | 63,800 | Award at $0 per share. | 0 |
